Pharmarise Holdings Corp. (JP:2796) has released an update.
Pharmarise Holdings Corp. reports a slight increase in net sales for the fiscal year ended May 31, 2024, but experiences significant declines in both operating and ordinary profits, with a notable net loss attributable to owners. Total assets grew over the year, while net assets per share decreased. Looking ahead, the company forecasts higher net sales and a modest rebound in operating profit for the following year.
For further insights into JP:2796 stock, check out TipRanks’ Stock Analysis page.
